Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b

Ophthalmology
Barry A SchechterWilliam Feuer

Abstract

To evaluate the long-term recurrence rate (>1 year) of conjunctival and corneal intraepithelial neoplasia (CIN) treated with topical interferon alfa-2b. Retrospective, noncomparative, interventional case series. Twenty-eight eyes of 26 patients from 2 institutions, treated between April 1997 and June 2005, with CIN lesions utilized topical interferon alfa-2b drops 4 times daily until clinical resolution was achieved. Patients' charts and clinical photographs were reviewed, and data were analyzed. All eyes were monitored for the possibility of recurrence with a minimum of 1-year follow-up from the time of documented clinical resolution. Complete clinical resolution of the CIN lesions was achieved in 27 of the 28 eyes treated (96.4%). One of the 28 eyes treated (3.6%) had only a partial response to treatment. For the 27 eyes with complete response, resolution occurred after a median of 2.0 months (range, 10 days-15 months). Eyes were treated for a median of 3.2 months (range, 1-15). Median follow-up after clinical resolution (tumor-free period) was 42.4 months (range, 14-89). One eye of the 27 analyzed (3.7%) experienced a recurrence. Side effects of treatment were limited to mild conjunctival hyperemia and follicular conjunctivi...Continue Reading

References

Sep 21, 1991·JAMA : the Journal of the American Medical Association·S BaronT K Hughes
Mar 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L CerezoR Magallón
Jan 1, 1988·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·C P HerbortM Schoeneich
Jun 1, 1989·The New England Journal of Medicine·J M McDonnellW J Martin
Sep 1, 1994·Archives of Ophthalmology·S L Maskin
Jan 1, 1994·Archives of Ophthalmology·D DauschE Schröder
Jan 24, 1998·American Journal of Ophthalmology·M W WilsonS A Madreperla
Mar 5, 2002·Ophthalmology·Ingrid U ScottGerard J Nuovo
Apr 1, 1965·Archives of Ophthalmology·J M CARROLL, T KUWABARA
Aug 4, 2004·American Journal of Ophthalmology·Irene A BarbazettoDavid H Abramson

❮ Previous
Next ❯

Citations

Jun 3, 2008·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·K Porubská, J M Rohrbach
Aug 6, 2009·Cornea·Yousuf A QureshiSander R Dubovy
Mar 30, 2013·Cornea·Amir Faramarzi, Sepehr Feizi
Jul 9, 2010·International Ophthalmology Clinics·Christine A KiireCarol L Karp
Apr 23, 2014·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·José Enrique Muñoz de Escalona RojasRosa María Bellido Muñoz
Jul 12, 2014·Cornea·Altan A ÖzcanGöksu H Şimdivar
Dec 2, 2014·International Ophthalmology Clinics·Jacob Pe'er
Jan 19, 2011·Ophthalmic Plastic and Reconstructive Surgery·Carol L ShieldsJerry A Shields
Dec 22, 2011·Ophthalmic Plastic and Reconstructive Surgery·Paul T Finger, Kimberly J Chin
Oct 12, 2013·Survey of Ophthalmology·Bruno F FernandesMiguel N Burnier
Aug 7, 2013·Ophthalmology·Minas Coroneo
Nov 13, 2010·Optometry : Journal of the American Optometric Association·Kathryn D Nelson, John J McSoley
Jun 27, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Leyla Asena, Dilek Dursun Altınörs
Jul 16, 2015·Asia-Pacific Journal of Ophthalmology·Rakhi KusumeshRajiv Kumar
Feb 2, 2011·The American Journal of Pathology·Jeanie ChuiNick Di Girolamo
Mar 14, 2012·Ocular Immunology and Inflammation·Ece Turan-VuralSuphi Acar
Feb 27, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alka MahaleLaura Asnaghi
Mar 16, 2017·Archivos de la Sociedad Española de Oftalmología·S Pagán Carrasco, D Arranz Maestro
Jun 5, 2018·Cornea·Claudine BelleriveArun D Singh
Jul 29, 2010·Ocular Immunology and Inflammation·Carol L KarpSonia H Yoo
Nov 16, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·N KenawyB E Damato
Jan 16, 2019·Ocular Oncology and Pathology·Pia R MendozaHans E Grossniklaus
Feb 12, 2017·Expert Review of Ophthalmology·Ibrahim O Sayed-AhmedCarol L Karp
Oct 16, 2018·Ocular Oncology and Pathology·Hershel PatelCurtis E Margo
Jun 27, 2019·Eye and Vision·Despoina TheotokaCarol L Karp
Nov 25, 2019·Ophthalmology and Therapy·Victoria M L Cohen, Roderick F O'Day
Feb 9, 2021·Case Reports in Ophthalmological Medicine·Mónica Gimeno-CarreroEnrique Mencía-Gutiérrez
Feb 11, 2021·Eye·Roland HӧllhumerPamela Michelow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.